发明授权
US5627200A .beta..sub.3 -Adrenoceptor agonists and antagonists for the treatment of
intestinal motility disorders, depression, prostate disease and
dyslipidemia
失效
β3肾上腺素受体激动剂和拮抗剂用于治疗肠蠕动障碍，抑郁症，前列腺疾病和血脂异常
- 专利标题： .beta..sub.3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia
- 专利标题（中）： β3肾上腺素受体激动剂和拮抗剂用于治疗肠蠕动障碍，抑郁症，前列腺疾病和血脂异常
-
申请号： US312027申请日： 1994-09-26
-
公开(公告)号： US5627200A公开(公告)日： 1997-05-06
- 发明人: David K. Kreutter , Robert L. Dow
- 申请人： David K. Kreutter , Robert L. Dow
- 申请人地址： NY New York
- 专利权人： Pfizer Inc
- 当前专利权人： Pfizer Inc
- 当前专利权人地址： NY New York
- 主分类号： A61K31/343
- IPC分类号： A61K31/343 ; A61K31/4025 ; A61K31/404 ; A61K31/422 ; A61K31/4245 ; A61K31/427 ; A61K31/38 ; A61K31/415 ; A61K31/42 ; A61K31/425
摘要：
This invention relates to methods for treating intestinal motility disorders, intestinal ulcerations, including inflammatory bowel disease, ulcerative colitis, Crohn's disease and proctitis, and gastrointestinal ulcerations, depression, prostate disease and dyslipidemia by administering a .beta..sub.3 -adrenoceptor antagonist or agonist.
公开/授权文献
- US4913756A Techniques for welding thermoplastic tubes 公开/授权日：1990-04-03